Journal of Biological Chemistry · 2014 · 28 citations · 54 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingMalignant NeoplasmsMelanocytic TumorsProtein Kinase CascadesSignal Transduction In CancerTumor BiologyCancer Signaling PathwaysErk SignalingExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingMacromolecular Complex FormationMelanocytic Tumor Molecular PathologyS100 ProteinsS100b Protein
S100B is a prognostic marker for malignant melanoma. Increasing S100B levels are predictive of advancing disease stage, increased recurrence, and low overall survival in malignant melanoma patients. Using S100B overexpression and shRNA(S100B) knockdown studies in melanoma cell lines, elevated S100B was found to enhance cell viability and modulate MAPK signaling by binding directly to the p90 ribosomal S6 kinase (RSK). S100B-RSK complex formation was shown to be Ca(2+)-dependent and to block ERK-dependent phosphorylation of RSK, at Thr-573, in its C-terminal kinase domain. Additionally, the overexpression of S100B sequesters RSK into the cytosol and prevents it from acting on nuclear targets. Thus, elevated S100B contributes to abnormal ERK/RSK signaling and increased cell survival in malignant melanoma.
54
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Rosario Donato, Brian R. Cannon, Guglielmo Sorci et al. · Current Molecular Medicine · 2012 · 1.3K citations · Full text
ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology
Xiangli Yang, Koichi Matsuda, Peter Bialek et al. · Cell · 2004 · 825 citations · Full text
Medicine, Biology, Molecular Biology +14
Philippe P. Roux, Bryan A. Ballif, Rana Anjum et al. · Proceedings of the National Academy of Sciences · 2004 · 741 citations · Full text